ADVENZYMES

Advanced Enzyme Technologies Share PriceAdvanced Enzyme Technologies

₹353.35
0.15 (0.04%)
As on 09 December, 2023 | 06:45 BSE: 540025 NSE: ADVENZYMESISIN: INE837H01020

Advanced Enzyme Technologies Performance

Day Range

  • Low 348.10
  • High 358.45
₹ 353.35

52 Week Range

  • Low 225.00
  • High 368.00
₹ 353.35
  • Open Price354.70
  • Previous Close353.20
  • Volume437598

Start SIP in Advanced Enzyme Technologies

Start SIP

Advanced Enzyme Technologies Share Price

  • Over 1 Month 6.03%
  • Over 3 Month 9.14%
  • Over 6 Month 27.86%
  • Over 1 Year 12.46%

Advanced Enzyme Technologies Key Statistics

P/E Ratio 31.7
PEG Ratio 1.1
Market Cap Cr 3,951
Price to Book Ratio 3.1
EPS 5
Dividend 1.4
Relative Strength Index 64.82
Money Flow Index 86.18
MACD Signal 3.92
Average True Range 13.24

Advanced Enzyme Technologies Investment Rating

  • Master Rating:
  • Advanced Enzyme Techs. has an operating revenue of Rs. 585.94 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 26% is great, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 19% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 46 which is a POOR score indicating inconsistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 148 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Advanced Enzyme Technologies Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 97858380777271
Operating Expenses Qtr Cr 70615958586155
Operating Profit Qtr Cr 27252321191115
Depreciation Qtr Cr 3333323
Interest Qtr Cr 0000000
Tax Qtr Cr 6666524
Net Profit Qtr Cr 1867171714814
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 321282
Operating Expenses Annual Cr 237200
Operating Profit Annual in Cr 7573
Depreciation Cr 1010
Interest Annual Cr 00
Tax Annual Cr 1918
Net Profit Annual Cr 5655
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 5037
Cash from Investing Activity Annual Cr -42-14
Cash from Financing Annual Activity Cr -12-11
Net Cash Flow Annual Cr -412
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 525480
Fixed Assets Annual Cr 154141
Total Non Current Assets Annual Cr 387353
Total Current Assets Annual Cr 189177
Total Assets Annual Cr 576530
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 4743
ROE Annual % 1111
ROCE Annual % 1415
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2730
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 158147139142139121132
Operating Expenses Qtr Cr 10710395100999091
Operating Profit Qtr Cr 51444442403140
Depreciation Qtr Cr 9989999
Interest Qtr Cr 1111111
Tax Qtr Cr 13121013869
Net Profit Qtr Cr 34293229261824
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 566536
Operating Expenses Annual Cr 384328
Operating Profit Annual in Cr 156201
Depreciation Cr 3535
Interest Annual Cr 22
Tax Annual Cr 3747
Net Profit Annual Cr 106120
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 140122
Cash from Investing Activity Annual Cr -298-25
Cash from Financing Annual Activity Cr -26-27
Net Cash Flow Annual Cr -18470
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,2351,089
Fixed Assets Annual Cr 350338
Total Non Current Assets Annual Cr 700663
Total Current Assets Annual Cr 722604
Total Assets Annual Cr 1,4221,268
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 115102
ROE Annual % 911
ROCE Annual % 1114
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 3439

Advanced Enzyme Technologies Technicals

EMA & SMA

Current Price
₹353.35
0.15 (0.04%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹333.32
  • 50 Day
  • ₹326.24
  • 100 Day
  • ₹318.06
  • 200 Day
  • ₹306.65
  • 20 Day
  • ₹330.58
  • 50 Day
  • ₹324.61
  • 100 Day
  • ₹323.06
  • 200 Day
  • ₹295.53

Advanced Enzyme Technologies Resistance and Support

PIVOT
₹353.3
Resistance
First Resistance 358.50
Second Resistance 363.65
Third Resistance 368.85
RSI 64.82
MFI 86.18
MACD Single Line 3.92
MACD 7.00
Support
First Resistance 348.15
Second Resistance 342.95
Third Resistance 337.80

Advanced Enzyme Technologies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 498,355 22,560,531 45.27
Week 1,354,876 48,734,883 35.97
1 Month 524,218 21,052,576 40.16
6 Month 330,087 16,705,720 50.61

Advanced Enzyme Technologies Result Highlights

Advanced Enzyme Technologies Synopsis

NSE-Chemicals-Specialty

Advanced Enzyme Tech is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 311.53 Cr. and Equity Capital is Rs. 22.37 Cr. for the Year ended 31/03/2023. Advanced Enzyme Technologies Ltd. is a Public Limited Listed company incorporated on 15/03/1989 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1989PLC051018 and registration number is 051018.
Market Cap 3,951
Sales 344
Shares in Float 6.04
No of funds 86
Yield 0.28
Book Value 7.52
U/D Vol ratio 1.9
LTDebt / Equity
Alpha
Beta 0.97

Advanced Enzyme Technologies

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 45.92%46.52%49.87%49.87%
Mutual Funds 5.84%7.08%5.29%5.25%
Foreign Portfolio Investors 22.27%21.89%21.86%21.74%
Individual Investors 15.28%14.23%13.28%13.42%
Others 10.69%10.28%9.7%9.72%

Advanced Enzyme Technologies Management

Name Designation
Mr. Vasant Rathi Non Executive Chairman
Mr. Mukund M Kabra Whole Time Director
Ms. Rasika Rathi Non Executive Director
Dr. Sunny Sharma Non Executive Director
Mr. Kedar Jagdish Desai Independent Director
Mr. Pramod Kasat Independent Director
Ms. Vandana Tilak Independent Director
Mr. Vinodkumar Jajoo Independent Director
Ms. Rajshree Patel Independent Director
Mr. Nitin Desmukh Independent Director

Advanced Enzyme Technologies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Advanced Enzyme Technologies Corporate Action

Date Purpose Remarks
2023-11-07 Quarterly Results
2023-08-12 Quarterly Results
2023-05-13 Audited Results & Dividend
2023-02-11 Quarterly Results
2022-11-11 Quarterly Results
Date Purpose Remarks
2023-08-05 FINAL Rs.1.00 per share(50%)Final Dividend
2023-05-20 INTERIM Rs.4.00 per share(200%)Interim Dividend
2022-08-12 FINAL Rs.1.00 per share(50%)Final Dividend
2021-09-01 FINAL Rs.0.90 per share(45%)Final Dividend

Advanced Enzyme Technologies MF Shareholding

Name Amount(cr)
ICICI Prudential Value Discovery Fund Growth 32,494
ICICI Prudential Equity & Debt Fund Growth 26,183
HDFC Small Cap Fund Growth 25,409
HDFC Multi Cap Fund Regular Growth 10,000
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3,271

Advanced Enzyme Technologies FAQs

What is Share Price of Advanced Enzyme Technologies ?

Advanced Enzyme Technologies share price is ₹353 As on 09 December, 2023 | 06:31

What is the Market Cap of Advanced Enzyme Technologies ?

The Market Cap of Advanced Enzyme Technologies is ₹3951.3 Cr As on 09 December, 2023 | 06:31

What is the P/E ratio of Advanced Enzyme Technologies ?

The P/E ratio of Advanced Enzyme Technologies is 31.7 As on 09 December, 2023 | 06:31

What is the PB ratio of Advanced Enzyme Technologies ?

The PB ratio of Advanced Enzyme Technologies is 3.1 As on 09 December, 2023 | 06:31

Q2FY23